City

Barcelona (1)

Hangzhou (1)

Madrid (1)

Murcia (1)

Salamanca (1)

Santander (1)

Condition

Double Hit Lymphoma (2)

Triple Hit Lymphoma (2)

Chronic Lymphocytic Leukemia (CLL) (1)

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified (1)

High Grade B-Cell Lymphoma, Not Otherwise Specified (1)

Multiple Myeloma (MM) (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

IDP Discovery Pharma S.L. (1)

Zhejiang Cancer Hospital (1)

Collaborator

Intervention

idp-121 (1)

selinexor+rchop (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

double hit lymphoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Double Hit Lymphoma, Triple Hit Lymphoma Trial in Hangzhou (Selinexor+RCHOP)

Recruiting

Double Hit Lymphoma
Triple Hit Lymphoma

Selinexor+RCHOP

Hangzhou, Zhenjiang, China

Zhejiang Cancer Hospital

Aug 2, 2023

Multiple Myeloma (MM), DLBCL, Not Otherwise Specified, Double Hit Lymphoma Trial in Spain (IDP-121)

Recruiting

Multiple Myeloma (MM)
+5 more

IDP-121

Santander, Cantabria, Spain
+4 more

Jun 19, 2023